Literature DB >> 17144824

Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001-2005).

François J Serres1, Valérie Chetboul, Renaud Tissier, Carolina Carlos Sampedrano, Vassiliki Gouni, Audrey P Nicolle, Jean-Louis Pouchelon.   

Abstract

OBJECTIVE: To determine the prevalence of Doppler echocardiography-derived evidence of pulmonary arterial hypertension (DEE-PAH) in dogs with mitral valve disease (MVD) classified according to the International Small Animal Cardiac Health Council (ISACHC) heart failure classification scheme and various echocardiographic and Doppler indices of MVD severity.
DESIGN: Retrospective case series. ANIMALS: 617 dogs examined from 2001 to 2005 with MVD in ISACHC classes I to III. PROCEDURES: Dogs were examined echocardiographically. Criteria used for systolic and diastolic DEE-PAH were detection of high tricuspid (> or = 2.5 m/s) and telediastolic pulmonic (> or = 2.0 m/s) valvular peak regurgitant jet velocities, respectively, by use of continuous-wave Doppler echocardiography.
RESULTS: 86 (13.9%) dogs with MVD had a diagnosis of DEE-PAH. Severity and prevalence of DEE-PAH increased with ISACHC class (3.0%, 16.9%, 26.7%, and 72.2% prevalences for ISACHC classes Ia, Ib, II, and III, respectively). A significant correlation between systolic or diastolic pulmonary arterial pressure and left atrial-to-aortic diameter ratio (LA/Ao) was detected. Doppler echocardiography-derived evidence of pulmonary arterial hypertension was detected in 18 dogs with values of LA/Ao within reference range, all of which had moderate (n = 2 dogs) or severe (16) mitral valve regurgitation on color Doppler imaging. CONCLUSIONS AND CLINICAL RELEVANCE: The prevalence and degree of DEE-PAH were related to the severity of MVD. Changes associated with DEEPAH may be detected in early stages of the disease, but only in dogs with severe mitral valve regurgitation.

Entities:  

Mesh:

Year:  2006        PMID: 17144824     DOI: 10.2460/javma.229.11.1772

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  29 in total

1.  Doppler echocardiographic evidence of pulmonary hypertension in dogs: a retrospective clinical investigation.

Authors:  P Paradies; P P Spagnolo; M E Amato; D Pulpito; M Sasanelli
Journal:  Vet Res Commun       Date:  2014-01-11       Impact factor: 2.459

2.  Clinical efficacy of tadalafil compared to sildenafil in treatment of moderate to severe canine pulmonary hypertension: a pilot study.

Authors:  J A Jaffey; S B Leach; L R Kong; K E Wiggen; S B Bender; C R Reinero
Journal:  J Vet Cardiol       Date:  2019-05-11       Impact factor: 1.701

3.  Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.

Authors:  Eric de Madron; Jonathan N King; Günther Strehlau; Regina Valle White
Journal:  Can Vet J       Date:  2011-11       Impact factor: 1.008

4.  Accuracy of Doppler echocardiographic estimates of pulmonary artery pressures in a canine model of pulmonary hypertension.

Authors:  Lydia C Soydan; Heidi B Kellihan; Melissa L Bates; Rebecca L Stepien; Daniel W Consigny; Alessandro Bellofiore; Christopher J Francois; Naomi C Chesler
Journal:  J Vet Cardiol       Date:  2015-01-16       Impact factor: 1.701

5.  Pre- and post-operative cardiac evaluation of dogs undergoing lobectomy and pneumonectomy.

Authors:  Meriç Kocatürk; Hakan Salci; Zeki Yilmaz; A Sami Bayram; Jørgen Koch
Journal:  J Vet Sci       Date:  2010-09       Impact factor: 1.672

6.  Unmasking of left heart dilation following treatment for precapillary pulmonary hypertension.

Authors:  Sarah Rogg; Justin D Thomason; Nathan Boyd
Journal:  Can Vet J       Date:  2021-11       Impact factor: 1.008

7.  Predictive model for the detection of pulmonary hypertension in dogs with myxomatous mitral valve disease.

Authors:  Shoma Mikawa; Yuichi Miyagawa; Noriko Toda; Yoshinori Tominaga; Naoyuki Takemura
Journal:  J Vet Med Sci       Date:  2014-10-16       Impact factor: 1.267

8.  Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease.

Authors:  M Borgarelli; J Abbott; L Braz-Ruivo; D Chiavegato; S Crosara; K Lamb; I Ljungvall; M Poggi; R A Santilli; J Haggstrom
Journal:  J Vet Intern Med       Date:  2015 Mar-Apr       Impact factor: 3.333

9.  Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure.

Authors:  Nobuyuki Kanno; Yasutomo Hori; Yuichi Hidaka; Seishiro Chikazawa; Kazutaka Kanai; Fumio Hoshi; Naoyuki Itoh
Journal:  J Vet Med Sci       Date:  2015-11-26       Impact factor: 1.267

10.  Diagnostic Value of Selected Echocardiographic Variables to Identify Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease.

Authors:  A Tidholm; K Höglund; J Häggström; I Ljungvall
Journal:  J Vet Intern Med       Date:  2015-09-14       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.